Clinical trial
Urine UbA52 is a Biomarker of Early Diabetic Nephropathy
NCT02204280 is registered in ClinicalTrials.gov with Hebei Medical University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Urine UbA52 is a Biomarker of Early Diabetic Nephropathy
- Lead sponsor
- Hebei Medical University Third Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2014
- Completion date
- July 31, 2015
- Enrollment
- 120 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic nephropathy